BioNTech SE (BNTX) Change in Intangibles (2021 - 2026)
BioNTech SE (BNTX) posted Change in Intangibles of $1.3 million for Q4 2025, up 140.57% sequentially from -$3.2 million in Q3 2025, and up 104.89% YoY from $624941.5 in Q4 2024.
Analysis
BioNTech SE (BNTX) Change in Intangibles (2021 - 2026) Analysis & Trends
BioNTech SE has reported Change in Intangibles for 2 years, with the latest figure at $1.3 million in Q4 2025.
- Quarterly Change in Intangibles rose 104.89% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$672.4 million (changed N/A YoY) and the FY2025 annual result came in at -$648.4 million, down 265.97% from the prior year.
- Change in Intangibles climbed to $1.3 million in Q4 2025 per BNTX's latest filing, from -$3.2 million in the prior quarter.
- Over five years, Change in Intangibles peaked at $1.3 million in Q4 2025 and troughed at -$644.3 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | BioNTech SE | 25.06 Bn | 11.41 Bn | 10.00 Mn | 2.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33 Bn |
| Mar 31, 2026 | 5.01 Bn |
| Dec 31, 2025 | 1.68 Bn |
| Sep 30, 2025 | 2.31 Bn |
| Jun 30, 2025 | 1.85 Bn |
| Mar 31, 2025 | 4.68 Bn |
| Dec 31, 2024 | 2.96 Bn |
| Sep 30, 2024 | 3.18 Bn |
| Jun 30, 2024 | 2.53 Bn |
| Mar 31, 2024 | 2.96 Bn |
| Dec 31, 2023 | 982.66 Mn |
| Sep 30, 2023 | 329.84 Mn |
| Mar 31, 2022 | 421.10 Mn |
| Dec 31, 2021 | -9.38 Mn |
| Sep 30, 2021 | -432.80 Mn |